SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
¶
– Release Delayed to: 8/10/07 ·As Of Filer Filing For·On·As Docs:Size Issuer Agent 6/12/07 Comscore, Inc. S-1/A¶ 12:3.8M Bowne - DC/FA |
Document/Exhibit Description Pages Size 1: S-1/A Pre-Effective Amendment to Registration Statement HTML 1.69M (General Form) 11: CORRESP ¶ Comment-Response or Other Letter to the SEC HTML 7K 12: CORRESP ¶ Comment-Response or Other Letter to the SEC HTML 29K 2: EX-3.1 Articles of Incorporation/Organization or By-Laws HTML 127K 3: EX-3.3 Articles of Incorporation/Organization or By-Laws HTML 25K 4: EX-3.4 Articles of Incorporation/Organization or By-Laws HTML 133K 5: EX-4.1 Instrument Defining the Rights of Security Holders HTML 8K 6: EX-10.19 Material Contract HTML 13K 7: EX-10.20 Material Contract HTML 60K 8: EX-10.21 Material Contract HTML 14K 9: EX-10.22 Material Contract HTML 415K 10: EX-23.1 Consent of Experts or Counsel HTML 7K
corresp2 |
Attn:
|
Russell Mancuso | |
Eduardo Aleman | ||
Brian Cascio | ||
Lynn Dicker |
Re: | comScore, Inc. | |||
Registration Statement on Form S-1 | ||||
File No. 333-141740 | ||||
Initially filed on April 2, 2007 | ||||
Amendment No. 3 filed on June 12, 2007 |
U. S. Securities and Exchange Commission
|
CONFIDENTIAL TREATMENT REQUESTED | |
BY COMSCORE, INC. | ||
Page 2 |
1. | We note your disclosure in response to prior comment 9. Please provide more specific disclosure regarding what you mean by “competitive” and “compare favorably.” For example, does this mean that you provide compensation that exceeds the compensation in a defined industry? |
U. S. Securities and Exchange Commission
|
CONFIDENTIAL TREATMENT REQUESTED | |
BY COMSCORE, INC. | ||
Page 3 |
2. | Please expand your response to prior comment 10 to demonstrate how the disclosure of the omitted information would cause competitive harm under the same standard that applies when you request confidential treatment of confidential trade secrets or confidential commercial or financial information pursuant to Securities Act Rule 406. |
3. | Please expand the disclosure mentioned in your response to prior comment 10 to discuss how the different bonus percentages were established for the named officers. |
4. | Please clarify how the factors you cite in response to prior comment 14 are applied. For example, if a transaction affects a director’s independence, does the audit committee reject the transaction? |
U. S. Securities and Exchange Commission
|
CONFIDENTIAL TREATMENT REQUESTED | |
BY COMSCORE, INC. | ||
Page 4 |
5. | We note the second paragraph of your response to prior comment 15. However, a transaction in the past three years during which the registrant issued the very securities now offered to the public by the selling stockholders is a relationship that should be disclosed in this section per Regulation S-K Item 507. |
6. | We note your revised disclosure in response to comment 35 in our letter to you dated April 27, 2007 that one of your selling stockholders is an affiliate of a registered broker-dealer. Unless this selling stockholder is able to make the representations in comment 35, it must be identified in the prospectus as an underwriter. |
U. S. Securities and Exchange Commission
|
CONFIDENTIAL TREATMENT REQUESTED | |
BY COMSCORE, INC. | ||
Page 5 |
7. | It appears that you included the disclosure in the prospectus because of the status of the entity as a significant security holder at the time of your transactions with the entity. Therefore, your related-party agreement should not be omitted from your registration statement. |
8. | We will continue our evaluation of your response to comment 40 in our Apri1 27, 2007 letter to you when you provide the information mentioned in the second paragraph of response 1 in your May 25 letter. |
U. S. Securities and Exchange Commission
|
CONFIDENTIAL TREATMENT REQUESTED | |
BY COMSCORE, INC. | ||
Page 6 |
U. S. Securities and Exchange Commission
|
CONFIDENTIAL TREATMENT REQUESTED | |
BY COMSCORE, INC. | ||
Page 7 |
U. S. Securities and Exchange Commission
|
CONFIDENTIAL TREATMENT REQUESTED | |
BY COMSCORE, INC. | ||
Page 8 |
cc:
|
Magid M. Abraham, Ph.D., comScore, Inc. | |
John M. Green, comScore, Inc. | ||
Christiana L. Lin, comScore, Inc. | ||
Robert G. Day | ||
Andrew J. Pitts, Cravath, Swaine & Moore LLP |
This ‘S-1/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/12/07 | |||
6/11/07 | ||||
6/8/07 | UPLOAD | |||
5/25/07 | S-1/A | |||
5/22/07 | ||||
4/27/07 | ||||
4/2/07 | S-1 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/12/24 Comscore, Inc. 10-K 12/31/23 112:13M 11/08/23 Comscore, Inc. 10-Q 9/30/23 66:6.5M 8/09/23 Comscore, Inc. 10-Q 6/30/23 67:6.5M 6/30/23 Comscore, Inc. S-8 6/30/23 4:96K 5/10/23 Comscore, Inc. 10-Q 3/31/23 62:6M 3/02/23 Comscore, Inc. 10-K 12/31/22 109:16M 11/09/22 Comscore, Inc. 10-Q 9/30/22 69:8.6M 8/09/22 Comscore, Inc. 10-Q 6/30/22 59:7.7M 6/29/22 Comscore, Inc. S-8 6/29/22 4:84K 5/10/22 Comscore, Inc. 10-Q 3/31/22 57:6.7M 3/02/22 Comscore, Inc. 10-K 12/31/21 103:15M 12/23/21 Comscore, Inc. S-8 12/23/21 8:298K 11/09/21 Comscore, Inc. 10-Q 9/30/21 58:8.3M 8/31/21 Comscore, Inc. S-3 8/30/21 3:393K 8/09/21 Comscore, Inc. 10-Q 6/30/21 59:9.5M 5/06/21 Comscore, Inc. 10-Q 3/31/21 63:7.1M 3/10/21 Comscore, Inc. 10-K 12/31/20 107:17M 11/09/20 Comscore, Inc. 10-Q 9/30/20 65:8.6M 8/10/20 Comscore, Inc. 10-Q 6/30/20 68:11M |